Any feedback?
Literature summary extracted from
- Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions (2012), EMBO Rep., 13, 930-938.
Cloned(Commentary)
| EC Number | Cloned (Comment) | Organism |
|---|---|---|
| 3.4.22.B70 | recombinant expression of wild-type Flag-tagged C13orf22l and C13orf22lcat mutant comprising amino acid residues 312-649 in HeLa cells | Danio rerio |
| 3.4.22.B70 | recombinant expression of YFP-tagged enzyme USPL1 in HeLa cell nucleoplasm, and of HA-tagged enzyme in Cajal bodies, co-expression with suicide inhibitor Strep-TEV-HA-SUMO-vinylmethylester, recombinant expression of truncated enzyme variant USPL1cat as His-GST-TEV-USPL1cat | Homo sapiens |
Protein Variants
| EC Number | Protein Variants | Comment | Organism |
|---|---|---|---|
| 3.4.22.B70 | C236S | site-directed mutagenesis, the mutant is not inhibited by suicide inhibitor Strep-TEV-HA-SUMO-vinylmethylester in contrast to the wild-type enzyme | Homo sapiens |
| 3.4.22.B70 | additional information | wild-type and inactive USPL1 variants rescue proliferation and coilin localization. Construction of His-GST-TEV-USPL1cat variants and analysis of their SUMO-AMC hydrolysis and SUMO binding. Four mutants show severe and two mutants moderate loss of activity, accompanied by severe or moderate reduction in binding | Homo sapiens |
| 3.4.22.B70 | W229L | site-directed mutagenesis, mutation to the residue found in USP2 and other ubiquitin-specific USPs dramatically impairs SUMO binding and cleavage | Homo sapiens |
| 3.4.22.B70 | W237F | site-directed mutagenesis, mutation to the residue found in USP2 and other ubiquitin-specific USPs dramatically impairs SUMO binding and cleavage | Homo sapiens |
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-(benzoylamino)benzoate | - |
Homo sapiens |  |
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3,4-diethoxybenzoyl)amino]benzoate | - |
Homo sapiens | |
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3,4-dimethoxybenzoyl)amino]benzoate | - |
Homo sapiens | |
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-aminobenzoyl)amino]benzoate | - |
Homo sapiens | |
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-fluorobenzoyl)amino]benzoate | - |
Homo sapiens | |
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-hydroxybenzoyl)amino]benzoate | - |
Homo sapiens | |
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-methoxybenzoyl)amino]benzoate | - |
Homo sapiens | |
| 3.4.22.B70 | 2-(4-chlorophenyl)-2-oxoethyl 4-[[3-(benzyloxy)benzoyl]amino]benzoate | - |
Homo sapiens | |
| 3.4.22.B70 | haemagglutinin-SUMO-vinylmethylester | a suicide inhibitor, Strep-TEV-HA-SUMO-vinylmethylester | Danio rerio | |
| 3.4.22.B70 | haemagglutinin-SUMO-vinylmethylester | a suicide inhibitor, Strep-TEV-HA-SUMO-vinylmethylester. Enzyme USPL1 requires its catalytic cysteine to react with the inhibitor | Homo sapiens |
Localization
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 3.4.22.B70 | Cajal body | - |
Danio rerio | 15030 | - |
| 3.4.22.B70 | Cajal body | enzyme USPL1 is a low-abundance protein that colocalizes with coilin in cajal bodies. USPL1 is an essential Cajal body component | Homo sapiens | 15030 | - |
| 3.4.22.B70 | nucleoplasm | - |
Homo sapiens | 5654 | - |
Molecular Weight [Da]
| EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|---|
| 3.4.22.B70 | 120000 | - |
- |
Homo sapiens |
Natural Substrates/ Products (Substrates)
| EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 3.4.22.B70 | additional information | Danio rerio | enzyme USPL1 neither binds nor cleaves ubiquitin, but is a potent SUMO isopeptidase both in vitro and in cells | ? | - |
? | |
| 3.4.22.B70 | additional information | Homo sapiens | enzyme USPL1 neither binds nor cleaves ubiquitin, but is a potent SUMO isopeptidase both in vitro and in cells | ? | - |
? | |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.4.22.B70 | Danio rerio | - |
- |
- |
| 3.4.22.B70 | Homo sapiens | Q5W0Q7 | - |
- |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 3.4.22.B70 | embryo | - |
Danio rerio | - |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 3.4.22.B70 | additional information | enzyme USPL1 neither binds nor cleaves ubiquitin, but is a potent SUMO isopeptidase both in vitro and in cells | Danio rerio | ? | - |
? | |
| 3.4.22.B70 | additional information | enzyme USPL1 neither binds nor cleaves ubiquitin, but is a potent SUMO isopeptidase both in vitro and in cells | Homo sapiens | ? | - |
? | |
| 3.4.22.B70 | additional information | enzyme USPL1 binds SUMO but not ubiquitin, no activity with ubiquitin-7-amido-4-methylcoumarin | Danio rerio | ? | - |
? | |
| 3.4.22.B70 | additional information | enzyme USPL1 binds SUMO but not ubiquitin, no activity with ubiquitin-7-amido-4-methylcoumarin | Homo sapiens | ? | - |
? | |
| 3.4.22.B70 | SUMO-7-amido-4-methylcoumarin + H2O | - |
Danio rerio | SuMo + 7-amino-4-methylcoumarin | - |
? | |
| 3.4.22.B70 | SUMO-7-amido-4-methylcoumarin + H2O | - |
Homo sapiens | SuMo + 7-amino-4-methylcoumarin | - |
? | |
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 3.4.22.B70 | C13orf22l | - |
Danio rerio |
| 3.4.22.B70 | SUMO isopeptidase | - |
Danio rerio |
| 3.4.22.B70 | SUMO isopeptidase | - |
Homo sapiens |
| 3.4.22.B70 | SUMO protease | - |
Danio rerio |
| 3.4.22.B70 | SUMO protease | - |
Homo sapiens |
| 3.4.22.B70 | SUMO-specific protease | - |
Danio rerio |
| 3.4.22.B70 | SUMO-specific protease | - |
Homo sapiens |
| 3.4.22.B70 | ubiquitin-specific protease-like 1 | - |
Homo sapiens |
| 3.4.22.B70 | USPL1 | - |
Homo sapiens |
Temperature Optimum [°C]
| EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|---|
| 3.4.22.B70 | 30 | - |
assay at | Danio rerio |
| 3.4.22.B70 | 30 | - |
assay at | Homo sapiens |
IC50 Value
| EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|---|
| 3.4.22.B70 | 0.00108 | - |
pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[[3-(benzyloxy)benzoyl]amino]benzoate | |
| 3.4.22.B70 | 0.00118 | - |
pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-(benzoylamino)benzoate | |
| 3.4.22.B70 | 0.00174 | - |
pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-fluorobenzoyl)amino]benzoate | |
| 3.4.22.B70 | 0.00186 | - |
pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-methoxybenzoyl)amino]benzoate | |
| 3.4.22.B70 | 0.00239 | - |
pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-methoxybenzoyl)amino]benzoate | |
| 3.4.22.B70 | 0.00354 | - |
pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-(benzoylamino)benzoate | |
| 3.4.22.B70 | 0.05 | - |
above, pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3,4-dimethoxybenzoyl)amino]benzoate | |
| 3.4.22.B70 | 0.05 | - |
above, pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3,4-diethoxybenzoyl)amino]benzoate | |
| 3.4.22.B70 | 0.05 | - |
above, pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-aminobenzoyl)amino]benzoate | |
| 3.4.22.B70 | 0.05 | - |
above, pH and temperature not specified in the publication | Homo sapiens | 2-(4-chlorophenyl)-2-oxoethyl 4-[(3-hydroxybenzoyl)amino]benzoate | |
General Information
| EC Number | General Information | Comment | Organism |
|---|---|---|---|
| 3.4.22.B70 | evolution | C13orf22l is a member of the C19 cysteine protease USP family, two families of SUMO isopeptidases are known, and C13orf22l represents a third type of SUMO protease. Zebrafish C13orf22l is a functional homologue of human USPL1 | Danio rerio |
| 3.4.22.B70 | evolution | USPL1 is a member of the C19 cysteine protease USP family, two families of SUMO isopeptidases are known, and USPL1 represents a third type of SUMO protease. W229, W237, Q405 and H421 are strictly conserved in USPL1 proteins, but different from residues in all other USPs | Homo sapiens |
| 3.4.22.B70 | malfunction | enzyme USPL1 depletion does not affect global sumoylation, but causes striking coilin mislocalization and impairs cell proliferation, functions that are not dependent on USPL1 catalytic activity | Homo sapiens |
| 3.4.22.B70 | malfunction | many cells of enzyme heterozygous mutants c13orf22lhi3662Tg/hi3662Tg reveal a striking accumulation of coilin in nucleoli. Enzyme disruption is lethal to the embryo in zebrafish with strong necrotic phenotype in the central nervous system and eye at 2 days post fertilization and death at 4-5 days post fertilization | Danio rerio |
| 3.4.22.B70 | additional information | enzyme USPL1 has a catalytic domain with a C236-H456-D472 triad. Two tryptophanes close to the catalytic cysteine are needed to stably position the C-terminal diglycine motif of SUMO in the substrate tunnel | Homo sapiens |
| 3.4.22.B70 | physiological function | C13orf22l is required for integrity of Cajal bodies in zebrafish embryos | Danio rerio |
| 3.4.22.B70 | physiological function | USPL1 is an essential Cajal body protein required for coilin localization and cell proliferation. USPL1 represents a third type of SUMO protease, with essential functions in Cajal body biology. The conserved areas in USPL1 might be involved in SUMO recognition | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
